Back to Journals » OncoTargets and Therapy » Volume 9

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
9,000 Dovepress* 7,931+ 1,510 9,441
PubMed Central* 1,069 408 1,477
Totals 9,000 1,918 10,918
*Since 21 April 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar